Share on LinkedInShare on LinkedIn

ARTICLE · 01 MAY 2026

Federal Cannabis Rescheduling: What Oklahoma OMMA Businesses Need To Know

On April 23, 2026, U.S. Attorney General Todd Blanche signed a final order moving FDA-approved marijuana drug products and state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act.

United StatesCannabis & Hemp

Important Notice: Fast-Moving Regulatory Issue

The information in this post is current only as of the publish date noted above. Federal cannabis rescheduling is a rapidly evolving area, and additional guidance from the U.S. Department of Justice, Drug Enforcement Administration, U.S. Department of the Treasury, Internal Revenue Service, Oklahoma Medical Marijuana Authority, and other agencies is expected in the coming weeks and months. Several of the items discussed below (including the scope of Section 280E relief, the application of import/export rules, and the application process for non-dispensary license types) remain unsettled. You should not rely on this post alone; it is critical to seek individualized legal and tax advice.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from